Jeffrey Robert Ajer - 30 Apr 2021 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Commercial Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
30 Apr 2021
Net transactions value
-$180,247
Form type
4
Filing time
28 Oct 2021, 19:48:40 UTC
Next filing
24 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $21,343 +342 +0.59% $62.41 58,592 30 Apr 2021 Direct F1
transaction BMRN Common Stock Sale $201,590 -2,739 -4.7% $73.60 55,853 26 Oct 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired by the reporting person on April 30, 2021, pursuant to the issuer's Employee Stock Purchase Plan.
F2 Trade made pursuant to a 10b5-1 plan executed on December 3, 2020.